{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:54:05Z","timestamp":1790679245248,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T00:00:00Z","timestamp":1611619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T00:00:00Z","timestamp":1611619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI078314"],"award-info":[{"award-number":["R01 AI078314"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI078314"],"award-info":[{"award-number":["R01 AI078314"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI078314"],"award-info":[{"award-number":["R01 AI078314"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHS-N272201400053C"],"award-info":[{"award-number":["HHS-N272201400053C"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHS-N272200800039C"],"award-info":[{"award-number":["HHS-N272200800039C"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01-AI061142"],"award-info":[{"award-number":["U01-AI061142"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI078314"],"award-info":[{"award-number":["R01 AI078314"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI078314"],"award-info":[{"award-number":["R01 AI078314"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI078314"],"award-info":[{"award-number":["R01 AI078314"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI078314"],"award-info":[{"award-number":["R01 AI078314"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008615","name":"UNC | UNC-Chapel Hill | Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill","doi-asserted-by":"publisher","award":["MCR012CCRI"],"award-info":[{"award-number":["MCR012CCRI"]}],"id":[{"id":"10.13039\/100008615","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA056036"],"award-info":[{"award-number":["P30 CA056036"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA056036"],"award-info":[{"award-number":["P30 CA056036"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study tests the hypothesis that an<jats:italic>Onchocerca volvulus<\/jats:italic>vaccine, consisting of two recombinant antigens (<jats:italic>Ov<\/jats:italic>-103 and<jats:italic>Ov<\/jats:italic>-RAL-2) formulated with the combination-adjuvant Advax-2, can induce protective immunity in genetically diverse Collaborative Cross recombinant inbred intercross mice (CC-RIX). CC-RIX lines were immunized with the<jats:italic>O. volvulus<\/jats:italic>vaccine and challenged with third-stage larvae. Equal and significant reductions in parasite survival were observed in 7 of 8 CC-RIX lines. Innate protective immunity was seen in the single CC-RIX line that did not demonstrate protective adaptive immunity. Analysis of a wide array of immune factors showed that each line of mice have a unique set of immune responses to vaccination and challenge suggesting that the vaccine is polyfunctional, inducing different equally-protective sets of immune responses based on the genetic background of the immunized host. Vaccine efficacy in genetically diverse mice suggests that it will also be effective in genetically complex human populations.<\/jats:p>","DOI":"10.1038\/s41541-020-00276-2","type":"journal-article","created":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T11:04:04Z","timestamp":1611659044000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Onchocerca volvulus bivalent subunit vaccine induces protective immunity in genetically diverse collaborative cross recombinant inbred intercross mice"],"prefix":"10.1038","volume":"6","author":[{"given":"Nathan M.","family":"Ryan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Pardo-Manuel","family":"de Villena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin E.","family":"Leiby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Yarmahmoodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1580-5245","authenticated-orcid":false,"given":"Nikolai","family":"Petrovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8429-0476","authenticated-orcid":false,"given":"Maria Elena","family":"Bottazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6100-6727","authenticated-orcid":false,"given":"Benjamin L.","family":"Makepeace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2389-6113","authenticated-orcid":false,"given":"Sara","family":"Lustigman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3072-2541","authenticated-orcid":false,"given":"David","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,26]]},"reference":[{"key":"276_CR1","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","volume":"392","author":"GBD Disease","year":"2018","unstructured":"Disease, G. B. D. & Injury, I. Prevalence C. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392, 1789\u20131858 (2018).","journal-title":"Lancet"},{"key":"276_CR2","first-page":"1","volume":"852","author":"Onchocerciasis and its control.","year":"1995","unstructured":"Onchocerciasis and its control. Report of a WHO Expert Committee on Onchocerciasis Control. World Health Organ Tech. Rep. Ser. 852, 1\u2013104 (1995).","journal-title":"World Health Organ Tech. Rep. Ser."},{"key":"276_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-018-0446-z","volume":"7","author":"Y Dadzie","year":"2018","unstructured":"Dadzie, Y., Amazigo, U. V., Boatin, B. A. & Seketeli, A. Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes. Infect. Dis. Poverty 7, 63 (2018).","journal-title":"Infect. Dis. Poverty"},{"key":"276_CR4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1179\/000349804225003442","volume":"98","author":"K Awadzi","year":"2004","unstructured":"Awadzi, K. et al. Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann. Trop. Med. Parasitol. 98, 359\u2013370 (2004).","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"276_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000072","volume":"1","author":"C Bourguinat","year":"2007","unstructured":"Bourguinat, C. et al. Genetic selection of low fertile Onchocerca volvulus by ivermectin treatment. PLoS Negl. Trop. Dis. 1, e72 (2007).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"276_CR6","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/S0020-7519(01)00131-X","volume":"31","author":"P Kohler","year":"2001","unstructured":"Kohler, P. The biochemical basis of anthelmintic action and resistance. Int. J. Parasitol. 31, 336\u2013345 (2001).","journal-title":"Int. J. Parasitol."},{"key":"276_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S0140-6736(96)11094-1","volume":"350","author":"J Gardon","year":"1997","unstructured":"Gardon, J. et al. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet 350, 18\u201322 (1997).","journal-title":"Lancet"},{"key":"276_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005576","volume":"11","author":"S Wanji","year":"2017","unstructured":"Wanji, S. et al. Ivermectin treatment of Loa loa hyper-microfilaraemic baboons (Papio anubis): assessment of microfilarial load reduction, haematological and biochemical parameters and histopathological changes following treatment. PLoS Negl. Trop. Dis. 11, e0005576 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"276_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004905","volume":"10","author":"L Senyonjo","year":"2016","unstructured":"Senyonjo, L. et al. Factors associated with ivermectin non-compliance and its potential role in sustaining onchocerca volvulus transmission in the West Region of Cameroon. PLoS Negl. Trop. Dis. 10, e0004905 (2016).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"276_CR10","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1126\/science.2218502","volume":"250","author":"HR Taylor","year":"1990","unstructured":"Taylor, H. R., Pacque, M., Munoz, B. & Greene, B. M. Impact of mass treatment of onchocerciasis with ivermectin on the transmission of infection. Science 250, 116\u2013118 (1990).","journal-title":"Science"},{"key":"276_CR11","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1186\/s13071-019-3826-8","volume":"12","author":"S Wanji","year":"2019","unstructured":"Wanji, S. et al. Implementation of test-and-treat with doxycycline and temephos ground larviciding as alternative strategies for accelerating onchocerciasis elimination in an area of loiasis co-endemicity: the COUNTDOWN consortium multi-disciplinary study protocol. Parasit. Vectors 12, 574 (2019).","journal-title":"Parasit. Vectors"},{"key":"276_CR12","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1586\/14760584.2015.1059281","volume":"14","author":"BL Makepeace","year":"2015","unstructured":"Makepeace, B. L., Babayan, S. A., Lustigman, S. & Taylor, D. W. The case for vaccine development in the strategy to eradicate river blindness (onchocerciasis) from Africa. Expert Rev. Vaccines 14, 1163\u20131165 (2015).","journal-title":"Expert Rev. Vaccines"},{"key":"276_CR13","doi-asserted-by":"publisher","first-page":"571","DOI":"10.2307\/3283385","volume":"79","author":"D Abraham","year":"1993","unstructured":"Abraham, D. et al. Survival and development of larval Onchocerca volvulus in diffusion chambers implanted in primate and rodent hosts. J. Parasitol. 79, 571\u2013582 (1993).","journal-title":"J. Parasitol."},{"key":"276_CR14","doi-asserted-by":"publisher","first-page":"783","DOI":"10.4269\/ajtmh.1993.49.783","volume":"49","author":"AM Lange","year":"1993","unstructured":"Lange, A. M., Yutanawiboonchai, W., Lok, J. B., Trpis, M. & Abraham, D. Induction of protective immunity against larval Onchocerca volvulus in a mouse model. Am. J. Trop. Med. Hyg. 49, 783\u2013788 (1993).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"276_CR15","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1128\/IAI.69.1.262-270.2001","volume":"69","author":"D Abraham","year":"2001","unstructured":"Abraham, D., Leon, O., Leon, S. & Lustigman, S. Development of a recombinant antigen vaccine against infection with the filarial worm Onchocerca volvulus. Infect. Immun. 69, 262\u2013270 (2001).","journal-title":"Infect. Immun."},{"key":"276_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S1471-4922(01)02211-5","volume":"18","author":"S Lustigman","year":"2002","unstructured":"Lustigman, S., James, E. R., Tawe, W. & Abraham, D. Towards a recombinant antigen vaccine against Onchocerca volvulus. Trends Parasitol. 18, 135\u2013141 (2002).","journal-title":"Trends Parasitol."},{"key":"276_CR17","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.ijpara.2014.04.006","volume":"44","author":"JA Hess","year":"2014","unstructured":"Hess, J. A. et al. Vaccines to combat river blindness: expression, selection and formulation of vaccines against infection with Onchocerca volvulus in a mouse model. Int J. Parasitol. 44, 637\u2013646 (2014).","journal-title":"Int J. Parasitol."},{"key":"276_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004586","volume":"10","author":"S Arumugam","year":"2016","unstructured":"Arumugam, S. et al. Vaccination of gerbils with Bm-103 and Bm-RAL-2 concurrently or as a fusion protein confers consistent and improved protection against brugia malayi infection. Plos Negl. Trop. Dis. 10, e0004586 (2016).","journal-title":"Plos Negl. Trop. Dis."},{"key":"276_CR19","doi-asserted-by":"publisher","first-page":"5920","DOI":"10.1016\/j.vaccine.2015.09.030","volume":"33","author":"N Petrovsky","year":"2015","unstructured":"Petrovsky, N. & Cooper, P. D. Advax, a novel microcrystalline polysaccharide particle engineered from delta inulin, provides robust adjuvant potency together with tolerability and safety. Vaccine 33, 5920\u20135926 (2015).","journal-title":"Vaccine"},{"key":"276_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004797","volume":"10","author":"JA Hess","year":"2016","unstructured":"Hess, J. A. et al. The immunomodulatory role of adjuvants in vaccines formulated with the recombinant antigens Ov-103 and Ov-RAL-2 against Onchocerca volvulus in mice. PLoS Negl. Trop. Dis. 10, e0004797 (2016).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"276_CR21","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1128\/IAI.70.6.2796-2804.2002","volume":"70","author":"AJ MacDonald","year":"2002","unstructured":"MacDonald, A. J. et al. Differential cytokine and antibody responses to adult and larval stages of Onchocerca volvulus consistent with the development of concomitant immunity. Infect. Immun. 70, 2796\u20132804 (2002).","journal-title":"Infect. Immun."},{"key":"276_CR22","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1128\/IAI.68.4.1905-1911.2000","volume":"68","author":"PS Turaga","year":"2000","unstructured":"Turaga, P. S. et al. Immunity to onchocerciasis: cells from putatively immune individuals produce enhanced levels of interleukin-5, gamma interferon, and granulocyte-macrophage colony-stimulating factor in response to Onchocerca volvulus larval and male worm antigens. Infect. Immun. 68, 1905\u20131911 (2000).","journal-title":"Infect. Immun."},{"key":"276_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007730","volume":"13","author":"PJ George","year":"2019","unstructured":"George, P. J. et al. Antibody responses against the vaccine antigens Ov-103 and Ov-RAL-2 are associated with protective immunity to Onchocerca volvulus infection in both mice and humans. PLoS Negl. Trop. Dis. 13, e0007730 (2019).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"276_CR24","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/cei.12841","volume":"186","author":"M Zeng","year":"2016","unstructured":"Zeng, M., Nourishirazi, E., Guinet, E. & Nouri-Shirazi, M. The genetic background influences the cellular and humoral immune responses to vaccines. Clin. Exp. Immunol. 186, 190\u2013204 (2016).","journal-title":"Clin. Exp. Immunol."},{"key":"276_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004556","volume":"10","author":"A Egli","year":"2014","unstructured":"Egli, A. et al. IL-28B is a key regulator of B- and T-cell vaccine responses against influenza. PLoS Pathog. 10, e1004556 (2014).","journal-title":"PLoS Pathog."},{"key":"276_CR26","doi-asserted-by":"crossref","unstructured":"Ganczak M., Skonieczna-Zydecka K., Drozd-Dabrowska M., Adler G. Possible impact of 190G > A CCR2 and delta32 CCR5 mutations on decrease of the HBV vaccine immunogenicity-A preliminary report. Int. J. Environ. Res. Public Health 14, (2017).","DOI":"10.3390\/ijerph14020166"},{"key":"276_CR27","doi-asserted-by":"publisher","first-page":"8988","DOI":"10.1016\/j.vaccine.2011.09.043","volume":"29","author":"IH Haralambieva","year":"2011","unstructured":"Haralambieva, I. H. et al. Genetic polymorphisms in host antiviral genes: associations with humoral and cellular immunity to measles vaccine. Vaccine 29, 8988\u20138997 (2011).","journal-title":"Vaccine"},{"key":"276_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001898","volume":"3","author":"BJ Hennig","year":"2008","unstructured":"Hennig, B. J. et al. Host genetic factors and vaccine-induced immunity to hepatitis B virus infection. PLoS ONE 3, e1898 (2008).","journal-title":"PLoS ONE"},{"key":"276_CR29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S1286-4579(01)01507-6","volume":"4","author":"A Hoerauf","year":"2002","unstructured":"Hoerauf, A. et al. The variant Arg110Gln of human IL-13 is associated with an immunologically hyper-reactive form of onchocerciasis (sowda). Microbes Infect. 4, 37\u201342 (2002).","journal-title":"Microbes Infect."},{"key":"276_CR30","doi-asserted-by":"publisher","first-page":"7515","DOI":"10.1073\/pnas.91.16.7515","volume":"91","author":"CG Meyer","year":"1994","unstructured":"Meyer, C. G. et al. HLA-D alleles associated with generalized disease, localized disease, and putative immunity in Onchocerca volvulus infection. Proc. Natl Acad. Sci. USA 91, 7515\u20137519 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"276_CR31","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1534\/genetics.111.132639","volume":"190","author":"Collaborative Cross C.","year":"2012","unstructured":"Collaborative Cross C. The genome architecture of the Collaborative Cross mouse genetic reference population. Genetics 190, 389\u2013401 (2012).","journal-title":"Genetics"},{"key":"276_CR32","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/ilar.52.1.24","volume":"52","author":"DW Threadgill","year":"2011","unstructured":"Threadgill, D. W., Miller, D. R., Churchill, G. A. & de Villena, F. P. The collaborative cross: a recombinant inbred mouse population for the systems genetic era. ILAR J. 52, 24\u201331 (2011).","journal-title":"ILAR J."},{"key":"276_CR33","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1534\/genetics.104.035709","volume":"170","author":"F Zou","year":"2005","unstructured":"Zou, F. et al. Quantitative trait locus analysis using recombinant inbred intercrosses: theoretical and empirical considerations. Genetics 170, 1299\u20131311 (2005).","journal-title":"Genetics"},{"key":"276_CR34","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1534\/genetics.116.198838","volume":"206","author":"A Srivastava","year":"2017","unstructured":"Srivastava, A. et al. Genomes of the mouse collaborative cross. Genetics 206, 537\u2013556 (2017).","journal-title":"Genetics"},{"key":"276_CR35","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0014-4894(88)90119-1","volume":"65","author":"D Abraham","year":"1988","unstructured":"Abraham, D., Grieve, R. B. & Mika-Grieve, M. Dirofilaria immitis: surface properties of third- and fourth-stage larvae. Exp. Parasitol. 65, 157\u2013167 (1988).","journal-title":"Exp. Parasitol."},{"key":"276_CR36","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/0014-4894(90)90075-N","volume":"71","author":"S Lustigman","year":"1990","unstructured":"Lustigman, S., Huima, T., Brotman, B., Miller, K. & Prince, A. M. Onchocerca volvulus: biochemical and morphological characteristics of the surface of third- and fourth-stage larvae. Exp. Parasitol. 71, 489\u2013495 (1990).","journal-title":"Exp. Parasitol."},{"key":"276_CR37","doi-asserted-by":"publisher","first-page":"373","DOI":"10.4269\/ajtmh.1988.39.373","volume":"39","author":"RB Grieve","year":"1988","unstructured":"Grieve, R. B., Abraham, D., Mika-Grieve, M. & Seibert, B. P. Induction of protective immunity in dogs to infection with Dirofilaria immitis using chemically-abbreviated infections. Am. J. Trop. Med Hyg. 39, 373\u2013379 (1988).","journal-title":"Am. J. Trop. Med Hyg."},{"key":"276_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003938","volume":"9","author":"HC Turner","year":"2015","unstructured":"Turner, H. C., Walker, M., Lustigman, S., Taylor, D. W. & Basanez, M. G. Human onchocerciasis: modelling the potential long-term consequences of a vaccination programme. PLoS Negl. Trop. Dis. 9, e0003938 (2015).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"276_CR39","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/0035-9203(83)90308-5","volume":"77","author":"B Kirkwood","year":"1983","unstructured":"Kirkwood, B., Smith, P., Marshall, T. & Prost, A. Relationships between mortality, visual acuity and microfilarial load in the area of the onchocerciasis control programme. Trans. R. Soc. Trop. Med Hyg. 77, 862\u2013868 (1983).","journal-title":"Trans. R. Soc. Trop. Med Hyg."},{"key":"276_CR40","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/S0140-6736(04)16151-5","volume":"363","author":"MP Little","year":"2004","unstructured":"Little, M. P., Breitling, L. P., Basanez, M. G., Alley, E. S. & Boatin, B. A. Association between microfilarial load and excess mortality in onchocerciasis: an epidemiological study. Lancet 363, 1514\u20131521 (2004).","journal-title":"Lancet"},{"key":"276_CR41","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1016\/j.celrep.2017.10.093","volume":"21","author":"JB Graham","year":"2017","unstructured":"Graham, J. B. et al. Extensive homeostatic T cell phenotypic variation within the collaborative cross. Cell Rep. 21, 2313\u20132325 (2017).","journal-title":"Cell Rep."},{"key":"276_CR42","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/gene.2013.59","volume":"15","author":"J Phillippi","year":"2014","unstructured":"Phillippi, J. et al. Using the emerging Collaborative Cross to probe the immune system. Genes Immun. 15, 38\u201346 (2014).","journal-title":"Genes Immun."},{"key":"276_CR43","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s12291-016-0556-y","volume":"31","author":"D Andure","year":"2016","unstructured":"Andure, D. et al. Immunization with Wuchereria bancrofti glutathione-S-transferase elicits a mixed Th1\/Th2 type of protective immune response against filarial infection in mastomys. Indian J. Clin. Biochem. 31, 423\u2013430 (2016).","journal-title":"Indian J. Clin. Biochem."},{"key":"276_CR44","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/sji.12208","volume":"80","author":"N Mahalakshmi","year":"2014","unstructured":"Mahalakshmi, N., Aparnaa, R. & Kaliraj, P. Evaluation of immune response elicited by inulin as an adjuvant with filarial antigens in mice model. Scand. J. Immunol. 80, 261\u2013270 (2014).","journal-title":"Scand. J. Immunol."},{"key":"276_CR45","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1084\/jem.122.3.517","volume":"122","author":"HO McDevitt","year":"1965","unstructured":"McDevitt, H. O. & Sela, M. Genetic control of the antibody response. I. Demonstration of determinant-specific differences in response to synthetic polypeptide antigens in two strains of inbred mice. J. Exp. Med. 122, 517\u2013531 (1965).","journal-title":"J. Exp. Med."},{"key":"276_CR46","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1128\/JVI.59.1.98-102.1986","volume":"59","author":"JW Templeton","year":"1986","unstructured":"Templeton, J. W., Holmberg, C., Garber, T. & Sharp, R. M. Genetic control of serum neutralizing-antibody response to rabies vaccination and survival after a rabies challenge infection in mice. J. Virol. 59, 98\u2013102 (1986).","journal-title":"J. Virol."},{"key":"276_CR47","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1056\/NEJM198909143211103","volume":"321","author":"CA Alper","year":"1989","unstructured":"Alper, C. A. et al. Genetic prediction of nonresponse to hepatitis B vaccine. N. Engl. J. Med. 321, 708\u2013712 (1989).","journal-title":"N. Engl. J. Med."},{"key":"276_CR48","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1084\/jem.173.3.531","volume":"173","author":"E Egea","year":"1991","unstructured":"Egea, E. et al. The cellular basis for lack of antibody response to hepatitis B vaccine in humans. J. Exp. Med. 173, 531\u2013538 (1991).","journal-title":"J. Exp. Med."},{"key":"276_CR49","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nrmicro1681","volume":"5","author":"B Guy","year":"2007","unstructured":"Guy, B. The perfect mix: recent progress in adjuvant research. Nat. Rev. Microbiol. 5, 505\u2013517 (2007).","journal-title":"Nat. Rev. Microbiol."},{"key":"276_CR50","first-page":"201","volume":"10","author":"TG Kimman","year":"2007","unstructured":"Kimman, T. G., Vandebriel, R. J. & Hoebee, B. Genetic variation in the response to vaccination. Community Genet. 10, 201\u2013217 (2007).","journal-title":"Community Genet."},{"key":"276_CR51","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1084\/jem.20082292","volume":"205","author":"D Gaucher","year":"2008","unstructured":"Gaucher, D. et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J. Exp. Med. 205, 3119\u20133131 (2008).","journal-title":"J. Exp. Med."},{"key":"276_CR52","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/ni.1688","volume":"10","author":"TD Querec","year":"2009","unstructured":"Querec, T. D. et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat. Immunol. 10, 116\u2013125 (2009).","journal-title":"Nat. Immunol."},{"key":"276_CR53","doi-asserted-by":"publisher","first-page":"695","DOI":"10.2307\/3283607","volume":"79","author":"M Trpis","year":"1993","unstructured":"Trpis, M., Scoles, G. A. & Struble, R. H. Cryopreservation of infective larvae of Onchocerca volvulus (Filarioidea: Onchocercidae). J. Parasitol. 79, 695\u2013700 (1993).","journal-title":"J. Parasitol."},{"key":"276_CR54","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1007\/s00335-012-9410-6","volume":"23","author":"CE Welsh","year":"2012","unstructured":"Welsh, C. E. et al. Status and access to the Collaborative Cross population. Mamm. Genome 23, 706\u2013712 (2012).","journal-title":"Mamm. Genome"},{"key":"276_CR55","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1046\/j.1365-3156.2000.00544.x","volume":"5","author":"A Hoerauf","year":"2000","unstructured":"Hoerauf, A. et al. Targeting of Wolbachia endobacteria in Litomosoides sigmodontis: comparison of tetracyclines with chloramphenicol, macrolides and ciprofloxacin. Trop. Med. Int. Health 5, 275\u2013279 (2000).","journal-title":"Trop. Med. Int. Health"},{"key":"276_CR56","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1006\/expr.2000.4525","volume":"95","author":"HL Smith","year":"2000","unstructured":"Smith, H. L. & Rajan, T. V. Tetracycline inhibits development of the infective-stage larvae of filarial nematodes in vitro. Exp. Parasitol. 95, 265\u2013270 (2000).","journal-title":"Exp. Parasitol."},{"key":"276_CR57","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1128\/AAC.47.5.1665-1671.2003","volume":"47","author":"F Fenollar","year":"2003","unstructured":"Fenollar, F., Maurin, M. & Raoult, D. Wolbachia pipientis growth kinetics and susceptibilities to 13 antibiotics determined by immunofluorescence staining and real-time PCR. Antimicrob. Agents Chemother. 47, 1665\u20131671 (2003).","journal-title":"Antimicrob. Agents Chemother."},{"key":"276_CR58","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/jac\/47.5.659","volume":"47","author":"PG Hermans","year":"2001","unstructured":"Hermans, P. G., Hart, C. A. & Trees, A. J. In vitro activity of antimicrobial agents against the endosymbiont Wolbachia pipientis. J. Antimicrob. Chemother. 47, 659\u2013663 (2001).","journal-title":"J. Antimicrob. Chemother."},{"key":"276_CR59","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0014-4894(02)00019-X","volume":"101","author":"RU Rao","year":"2002","unstructured":"Rao, R. U., Moussa, H. & Weil, G. J. Brugia malayi: effects of antibacterial agents on larval viability and development in vitro. Exp. Parasitol. 101, 77\u201381 (2002).","journal-title":"Exp. Parasitol."},{"key":"276_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006977","volume":"12","author":"JB Patton","year":"2018","unstructured":"Patton, J. B. et al. Development of Onchocerca volvulus in humanized NSG mice and detection of parasite biomarkers in urine and serum. PLoS Negl. Trop. Dis. 12, e0006977 (2018).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"276_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188916","volume":"12","author":"F Boin","year":"2017","unstructured":"Boin, F. et al. Flow cytometric discrimination of seven lineage markers by using two fluorochromes. PLoS ONE 12, e0188916 (2017).","journal-title":"PLoS ONE"},{"key":"276_CR62","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3389\/fimmu.2017.00130","volume":"8","author":"W Goh","year":"2017","unstructured":"Goh, W. & Huntington, N. D. Regulation of murine natural killer cell development. Front Immunol. 8, 130 (2017).","journal-title":"Front Immunol."},{"key":"276_CR63","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/cyto.a.22012","volume":"81","author":"S Rose","year":"2012","unstructured":"Rose, S., Misharin, A. & Perlman, H. A novel Ly6C\/Ly6G-based strategy to analyze the mouse splenic myeloid compartment. Cytom. A 81, 343\u2013350 (2012).","journal-title":"Cytom. A"},{"key":"276_CR64","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc.: Ser. B 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc.: Ser. B"}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-020-00276-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-020-00276-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-020-00276-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:35:48Z","timestamp":1724373348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-020-00276-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,26]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["276"],"URL":"https:\/\/doi.org\/10.1038\/s41541-020-00276-2","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,26]]},"assertion":[{"value":"25 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17"}}